Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Corcept Therapeutics Inc shares valued at $462,800 were sold by Guyer William on Oct 01 ’24. At $46.28 per share, Guyer William sold 10,000 shares. The insider’s holdings dropped to 5,796 shares worth approximately $0.26 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Robb Gary Charles sold 11,000 shares, netting a total of over 509,080 in proceeds. Following the sale of shares at $46.28 each, the insider now holds 22,772 shares.
Before that, Robb Gary Charles had added 11,000 shares to its account. In a trade valued at $509,080, the Officer bought Corcept Therapeutics Inc shares for $46.28 each.
As published in a research note from Truist on November 06, 2023, Corcept Therapeutics Inc [CORT] has been rated up from a Hold to a Buy and the price target has been revised to $38 from $29. Analysts at SVB Securities started covering the stock with ‘”a Market perform”‘ outlook in a report released in mid April. As of April 04, 2023, Piper Sandler has initiated its “an Overweight” rating for CORT. Earlier on February 15, 2023, Jefferies downgraded its rating. Their new recommendation was “a Hold” for CORT stock which previously was a “a Buy”.
Analyzing CORT Stock Performance
During the last five days, there has been a surge of approximately 4.07%. Over the course of the year, Corcept Therapeutics Inc shares have jumped approximately 38.67%. Shares of the company reached a 52-week high of $47.71 on 10/01/24 and a 52-week low of $20.84 on 04/22/24. A 50-day SMA is recorded $37.29, while a 200-day SMA reached $29.33. Nevertheless, trading volume fell to 0.95 million shares from 0.8 million shares the previous day.
Support And Resistance Levels for Corcept Therapeutics Inc (CORT)
According to the 24-hour chart, there is a support level at 44.39, which, if violated, would cause prices to drop to 43.74. In the upper region, resistance lies at 46.04. The next price resistance is at 47.04. RSI (Relative Strength Index) is 68.52 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.72, which suggests the price will increase in the coming days. Percent R is at 27.00%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
